These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16966724)

  • 1. Linking pharmacogenetics-based diagnostics and drugs for personalized medicine.
    Garrison LP; Austin MJ
    Health Aff (Millwood); 2006; 25(5):1281-90. PubMed ID: 16966724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intersection of biotechnology and pharmacogenomics: health policy implications.
    Phillips KA
    Health Aff (Millwood); 2006; 25(5):1271-80. PubMed ID: 16966723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacogenetics: towards personalized medicine].
    Gurwitz D; Rehavi M
    Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the value of genomic diagnostics: implications for clinical practice and public policy.
    Issa AM
    Adv Health Econ Health Serv Res; 2008; 19():191-206. PubMed ID: 19548519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine: reality and reality checks.
    Leeder JS; Spielberg SP
    Ann Pharmacother; 2009 May; 43(5):963-6. PubMed ID: 19417116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment and pharmacogenetics in molecular and genomic epidemiology.
    Park SK; Choi JY
    J Prev Med Public Health; 2009 Nov; 42(6):371-6. PubMed ID: 20009483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation towards personalized medicine in Multiple Sclerosis.
    Miller A; Avidan N; Tzunz-Henig N; Glass-Marmor L; Lejbkowicz I; Pinter RY; Paperna T
    J Neurol Sci; 2008 Nov; 274(1-2):68-75. PubMed ID: 18789804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of pharmacoproteomics in the development of personalized medicine.
    Jain KK
    Pharmacogenomics; 2004 Apr; 5(3):331-6. PubMed ID: 15102547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From genomic landscapes to personalized cancer management-is there a roadmap?
    Swanton C; Caldas C
    Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is personalized medicine finally arriving?
    Allison M
    Nat Biotechnol; 2008 May; 26(5):509-17. PubMed ID: 18464779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current impact of gene technology on healthcare. A map of economic assessments.
    Rogowski W
    Health Policy; 2007 Feb; 80(2):340-57. PubMed ID: 16678930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance of biomarker-based tests for application in clinical practice: criteria and obstacles.
    Pirmohamed M
    Clin Pharmacol Ther; 2010 Dec; 88(6):862-6. PubMed ID: 20981006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic medicine: bringing biomarkers to clinical medicine.
    Seo D; Ginsburg GS
    Curr Opin Chem Biol; 2005 Aug; 9(4):381-6. PubMed ID: 16006183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How molecular medicine transforms policy (and everything else).
    Kean MA; Batchelder KF
    J Biolaw Bus; 2004; 7(3):16-9. PubMed ID: 15460603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics. Medicine's future in our molecules.
    Larson L
    Trustee; 2000 Jan; 53(1):8-12, 1. PubMed ID: 11785218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.